Presentation, echocardiographic findings and long-term outcomes in children with familial dilated cardiomyopathy

Progress in Pediatric Cardiology

Volumn 31, Issue 2, 2011, Pages 119-122

  Weintraub, Robert G ^a   Nugent, Alan W ^c   Davis, Andrew ^a   King, Ingrid ^a   Bharucha, Tara ^a   Daubeney, Piers E F ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Dilated cardiomyopathy; Genetics; Pediatric

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CHILD; CHILD HOSPITALIZATION; CHILDHOOD MORTALITY; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; FAMILIAL DILATED CARDIOMYOPATHY; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

EID: 79955467444     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2011.02.009     Document Type: Article

References (19)

1. Boucek M.M., Edwards L.B., Keck B.M., Trulock E.P., Taylor D.O., Hertz M.I. Registry of the International Society for Heart and Lung Transplantation: eighth official pediatric report-2005. J Heart Lung Transplant 2005, 24:968-982.
2. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. Jama 2002, 287:1308-1320.
3. Maron B.J. Sudden death in young athletes. N Engl J Med 2003, 349:1064-1075.
4. Nugent A.W., Daubeney P.E., Chondros P., et al. National Australian Childhood Cardiomyopathy Study. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003, 348:1639-1646.
5. Jefferies J.L., Towbin J.A. Dilated cardiomyopathy. Lancet 2010, 375:752-762.
6. Daubeney P.E., Nugent A.W., Chondros P., et al. National Australian Childhood Cardiomyopathy Study. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation 2006, 114:2671-2678.
7. Maron B.J., Towbin J.A., Thiene G., et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006, 113(14):1807-1816.
8. Sluysmans T., Colan S.D. Theoretical and empirical derivation of cardiovascular allometric relationships in children. J Appl Physiol 2005, 99:445-457. [see comment].
9. Colan S.D., Parness I.A., Spevak P.J., Sanders S.P. Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility. J Am Coll Cardiol 1992, 19:619-629.
10. Spirito P., Chiarella F., Carratino L., Berisso M.Z., Bellotti P., Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 1989, 320:749-755.
11. Michels V.V., Driscoll D.J., Miller F.A., et al. Progression of familial and non-familial dilated cardiomyopathy: long term follow-up. Heart 2003, 89:757-761.
12. Matitiau A., Perez-Atayde A., Sanders S.P., et al. Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation 1994, (90):1310-1318. [comment].
13. Akagi T., Benson L.N., Lightfoot N.E., Chin K., Wilson G., Freedom R.M. Natural history of dilated cardiomyopathy in children. Am Heart J 1991, 121:1502-1506.
14. Friedman R.A., Moak J.P., Garson A. Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol 1991, (18):152-156. [see comment].
15. Tsirka A.E., Trinkaus K., Chen S.C., Lipshultz S.E., et al. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol 2004, 44:391-397.
16. Arola A., Tuominen J., Ruuskanen O., Jokinen E. Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics 1998, 101:369-376.
17. Towbin J.A., Lowe A.M., Colan S.D., et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. Jama 1867, 296:1867-1876.
18. Shaddy R.E., Boucek M.M., Hsu D.T., et al. Carvedilol for children and adolescents with heart failure. Jama 2007, 298:1171-1179.
19. Lakdawala N.K., Dellefave L., Redwood C.S., et al. Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy. J Am Coll Cardiol 2010, 55:320-329.